Bibliography
- ABRAMOVITZ M, ADAM M, BOIE Y et al.: The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta (2000) 1483 (2):285–293.
- OLEMAN RA, SMITH WL, NARUMIYA S: International Union of Pharmacology classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacol. Rev. (1994) 46:205–229.
- REYER MD: Prostaglandin receptors in the kidney: anew route for intervention? J. Exp. Nephrol. (1998) 6(3):180–188.
- AKATA K, MARUYAMA T, SEKI A et al: Demonstration of patho-physiological roles of PGE2 receptor EP4 subtype using a novel EP4 subtype selective agonist, ONO-AE1-329. Prostaglandins Med. (1999) 59 (20 :1–6.
- ASTRAZENECA PLC: Annual Report 1999. (23 February 2000).
- UEL R, LACOMBE P, ABRAMOVITZ M et al.: New class ofbiphenylene dibenzazocinones as potent ligands for the human EP1 prostanoid receptor. Bioorg. Med. Chem. Lett. (1999) 9(18):2699–2704.
- LEY KR, HUNTER JC, EGLEN RM, SMITH JA: The role of IPprostanoid receptors in inflammatory pain. Trends Pharmacol. ScL (1998) 19 (4) :141–171.